Business Description
Dr. Martens PLC
28 Jamestown Road, Camden, London, GBR, NW1 7BY
Compare
Compare
Traded in other countries / regions
3U2.Germany
•
DOCS.Mexico
•
DOCS.UK
•
DOCMF.USA
Description
Dr. Martens PLC is engaged in the business of footwear. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories. Geographically, it derives a majority of revenue from EMEA and also has a presence in the Americas and APAC.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.58 | |||||
| Equity-to-Asset | 0.38 | |||||
| Debt-to-Equity | 1.2 | |||||
| Debt-to-EBITDA | 1.49 | |||||
| Interest Coverage | 16.38 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 8.17 | |||||
| Beneish M-Score | 0 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 25.9 | |||||
| 3-Year EBITDA Growth Rate | 50.1 | |||||
| 3-Year EPS without NRI Growth Rate | 120 | |||||
| 3-Year FCF Growth Rate | 59.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate Industry Rank | 11 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | 16.07 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 44.91 | |||||
| 9-Day RSI | 49.01 | |||||
| 14-Day RSI | 51.04 | |||||
| 6-1 Month Momentum % | -7.14 | |||||
| 12-1 Month Momentum % | -33.95 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.86 | |||||
| Quick Ratio | 2.07 | |||||
| Cash Ratio | 1.47 | |||||
| Days Inventory | 127.13 | |||||
| Days Sales Outstanding | 25.56 | |||||
| Days Payable | 55.76 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.12 | |||||
| Dividend Payout Ratio | 0.07 | |||||
| Forward Dividend Yield % | 2.12 | |||||
| 5-Year Yield-on-Cost % | 2.12 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 63.72 | |||||
| Operating Margin % | 24.89 | |||||
| Net Margin % | 19.95 | |||||
| ROE % | 79.77 | |||||
| ROA % | 24.48 | |||||
| ROIC % | 36.45 | |||||
| ROC (Joel Greenblatt) % | 120.58 | |||||
| ROCE % | 38.6 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 14.33 | |||||
| Forward PE Ratio | 0.29 | |||||
| PE Ratio without NRI | 14.86 | |||||
| Price-to-Owner-Earnings | 13.65 | |||||
| PS Ratio | 2.87 | |||||
| PB Ratio | 7.91 | |||||
| Price-to-Tangible-Book | 37.06 | |||||
| Price-to-Free-Cash-Flow | 16.31 | |||||
| Price-to-Operating-Cash-Flow | 14.09 | |||||
| EV-to-EBIT | 12.11 | |||||
| EV-to-Forward-EBIT | 10.34 | |||||
| EV-to-EBITDA | 10.41 | |||||
| EV-to-Forward-EBITDA | 9.27 | |||||
| EV-to-Revenue | 3.04 | |||||
| EV-to-Forward-Revenue | 2.62 | |||||
| EV-to-FCF | 17.92 | |||||
| Price-to-Graham-Number | 4.99 | |||||
| Earnings Yield (Greenblatt) % | 8.26 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | 908.3 | ||
| EPS (TTM) (£) | 0.181 | ||
| Beta | 0 | ||
| Volatility % | 40.99 | ||
| 14-Day RSI | 51.04 | ||
| 14-Day ATR (£) | 0.142361 | ||
| 20-Day SMA (£) | 2.6122 | ||
| 12-1 Month Momentum % | -33.95 | ||
| 52-Week Range (£) | 1.747 - 4.482 | ||
| Shares Outstanding (Mil) | 1,000.28 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Dr. Martens PLC Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||